Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-16-019805)

Filing Details

Accession Number:: 0000899243-16-019805
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-05-12 18:38:52
Reporting Period:: 2016-05-11

Filing Date:: 2016-05-12
Accepted Time:: 2016-05-12 18:38:52
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1566373	Spring Bank Pharmaceuticals Inc.	SBPH	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1339402	J Martin Driscoll	C/O Spring Bank Pharmaceuticals, Inc. 86 South Street Hopkinton MA 01748	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-05-11	12,500	$12.00	12,500	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

Reports the purchase of shares in the underwritten public offering of common stock of Spring Bank Pharmaceuticals, Inc.